Underdiagnosed GSM Impacts Millions of Postmenopausal Women

Underdiagnosed GSM Impacts Millions of Postmenopausal Women

arabic.euronews.com

Underdiagnosed GSM Impacts Millions of Postmenopausal Women

Affecting 27-84% of postmenopausal women, Genitourinary Syndrome of Menopause (GSM) causes vaginal dryness, pain during intercourse, and urinary issues, often misdiagnosed as urinary tract infections; effective treatments are available, including hormone therapy and vaginal moisturizers.

Arabic
United States
HealthGender IssuesWomens HealthMenopauseSexual HealthHormone Replacement TherapyGsmGenitourinary Syndrome Of Menopause
Northwestern MedicineThe North American Menopause SocietyFda
Dr. Lauren StreicherStephanie FaubionDr. James SimonCheryl Kingsberg
How do hormonal changes contribute to the development and progression of GSM symptoms?
GSM, previously known as vulvovaginal atrophy, encompasses broader symptoms than previously understood. Low estrogen causes changes in the urogenital environment, increasing infection risk and discomfort. The condition's impact extends beyond sexual health, affecting daily activities and relationships.
What is the global health significance of the underdiagnosis of Genitourinary Syndrome of Menopause (GSM)?
Genitourinary syndrome of menopause (GSM) affects 27-84% of postmenopausal women, yet many remain undiagnosed. Symptoms include vaginal dryness, itching, pain during intercourse, and urinary problems. These worsen with age, impacting daily life and relationships.
What are the long-term implications of untreated GSM, and how can healthcare systems improve early detection and management?
While treatments exist, including vaginal moisturizers, lubricants, and hormone therapy, many women remain undiagnosed due to overlapping symptoms with urinary tract infections. Untreated GSM can lead to severe infections. Increased awareness and improved diagnosis are crucial for effective management and improved quality of life.

Cognitive Concepts

1/5

Framing Bias

The framing of the article is generally balanced, presenting both the challenges of GSM and the availability of effective treatments. However, the headline (if any) and introduction could be improved to emphasize the prevalence and treatability of the condition rather than focusing solely on the symptoms.

3/5

Bias by Omission

The article focuses heavily on the symptoms and treatments of GSM, but it omits discussion of potential alternative or complementary therapies beyond hormone replacement and pelvic floor exercises. It also doesn't address the potential long-term effects of untreated GSM or the psychological impact on partners.

2/5

False Dichotomy

The article presents a somewhat false dichotomy by emphasizing hormone replacement therapy as the most effective treatment, while acknowledging other options but without fully exploring their efficacy or suitability for all patients. This could lead readers to believe HRT is the only viable solution.

Sustainable Development Goals

Good Health and Well-being Positive
Direct Relevance

The article discusses GSM, a condition affecting many postmenopausal women, causing discomfort and impacting sexual health and daily life. The article highlights the importance of accurate diagnosis and effective treatments, which directly contributes to improving women's health and well-being. The availability of treatments like vaginal moisturizers, lubricants, and hormone therapy positively impacts the management of GSM symptoms and improves quality of life.